Search research articles
Contact Us
Filters
Showing results (61-70 of 172) with videos related to
Page
of 18
Sort By:
American Journal of Clinical Pathology
|
April 11, 2017
HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3
Amy Chadburn, Jonathan Said, Dita Gratzinger, et al.
American Journal of Clinical Pathology
|
April 11, 2017
T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting: 2015 SH/EAHP Workshop Report-Part 4
Dita Gratzinger, Daphne de Jong, Elaine S Jaffe, et al.
Blood
|
August 8, 2018
Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?
Yasodha Natkunam, Dita Gratzinger, Amy Chadburn, et al.
Cancer Research
|
May 9, 2018
Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses
Tiziana Vaisitti, Esteban Braggio, John N Allan, et al.
Cancer Research
|
November 12, 2009
Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation
Giorgio Cattoretti, Jonathan Mandelbaum, Nancy Lee, et al.
American Journal of Clinical Pathology
|
April 11, 2017
EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1
Yasodha Natkunam, John R Goodlad, Amy Chadburn, et al.
Journal of Virology
|
February 20, 2009
Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma
Daniel L Di Bartolo, Elizabeth Hyjek, Shannon Keller, et al.
Nature Immunology
|
January 30, 2007
Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI
Weifeng Xu, Bing He, April Chiu, et al.
Blood
|
May 26, 2005
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010
Lawrence D Kaplan, Jeannette Y Lee, Richard F Ambinder, et al.
Cancer Cell
|
December 16, 2010
BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma
Jonathan Mandelbaum, Govind Bhagat, Hongyan Tang, et al.
Page
of 18
Search research articles
Search
Showing results (61-70 of 172) with videos related to
Sort By:
Page
of 18
American Journal of Clinical Pathology
|
April 11, 2017
HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3
Amy Chadburn, Jonathan Said, Dita Gratzinger, et al.
American Journal of Clinical Pathology
|
April 11, 2017
T- and NK-Cell Lymphomas and Systemic Lymphoproliferative Disorders and the Immunodeficiency Setting: 2015 SH/EAHP Workshop Report-Part 4
Dita Gratzinger, Daphne de Jong, Elaine S Jaffe, et al.
Blood
|
August 8, 2018
Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?
Yasodha Natkunam, Dita Gratzinger, Amy Chadburn, et al.
Cancer Research
|
May 9, 2018
Novel Richter Syndrome Xenograft Models to Study Genetic Architecture, Biology, and Therapy Responses
Tiziana Vaisitti, Esteban Braggio, John N Allan, et al.
Cancer Research
|
November 12, 2009
Targeted disruption of the S1P2 sphingosine 1-phosphate receptor gene leads to diffuse large B-cell lymphoma formation
Giorgio Cattoretti, Jonathan Mandelbaum, Nancy Lee, et al.
American Journal of Clinical Pathology
|
April 11, 2017
EBV-Positive B-Cell Proliferations of Varied Malignant Potential: 2015 SH/EAHP Workshop Report-Part 1
Yasodha Natkunam, John R Goodlad, Amy Chadburn, et al.
Journal of Virology
|
February 20, 2009
Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma
Daniel L Di Bartolo, Elizabeth Hyjek, Shannon Keller, et al.
Nature Immunology
|
January 30, 2007
Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI
Weifeng Xu, Bing He, April Chiu, et al.
Blood
|
May 26, 2005
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010
Lawrence D Kaplan, Jeannette Y Lee, Richard F Ambinder, et al.
Cancer Cell
|
December 16, 2010
BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma
Jonathan Mandelbaum, Govind Bhagat, Hongyan Tang, et al.
Page
of 18